To confirm whether chemo-sensitivity score was an independent risk factor for OS in TCGA CN-AML patients, association between the score and some known risk factors for AML outcome, including cytogenetic risk, NPM1 mutations, FLT3-IDT mutations, CEBPA mutations, IDH mutations, and DMNT3A R882 mutations were analyzed. This evidence concerns the gene CEBPA and acute myeloid leukemia.